Protagenic Therapeutics Free Cash Flow Generation Index
Protagenic Therapeutics free cash flow generation index. Protagenic Therapeutics (PTIX) has a Free Cash Flow Generation Index of 1.00x as of December 2010. Free cash flow of $1.72 Million represents 1% of operating cash flow ($1.72 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Protagenic Therapeutics (1999–2008)
Free cash flow generation index of Protagenic Therapeutics from 1999 to 2008. Historical FCF Generation Index trend for Protagenic Therapeutics across 7 annual periods. See financial agility of Protagenic Therapeutics to measure the company's free cash flow as a share of total liabilities.
Protagenic Therapeutics Free Cash Flow Generation Index by Year (1999–2008)
Protagenic Therapeutics free cash flow generation index by year from 1999 to 2008. Year-by-year Free Cash Flow Generation Index for Protagenic Therapeutics. For the full cash flow conversion analysis, see Protagenic Therapeutics operating cash flow efficiency.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2008 | 0.53x | $2.33 Million | $4.36 Million | $2.03 Million | ▼ -41.8% |
| 2006 | 0.92x | $854.00K | $931.00K | $77.00K | ▲ +339.8% |
| 2003 | 0.21x | $390.00K | $1.87 Million | $1.48 Million | ▼ -13.1% |
| 2002 | 0.24x | $563.00K | $2.35 Million | $1.78 Million | ▲ +115.8% |
| 2001 | -1.52x | $-2.29 Million | $1.50 Million | $3.79 Million | ▼ -2017.1% |
| 2000 | 0.08x | $278.00K | $3.51 Million | $3.23 Million | ▼ -89.5% |
| 1999 | 0.76x | $250.00K | $331.00K | $81.00K | — |